Recently, it is shown that GSDMD-dependent pyroptosis is triggered in silica-treated AMs by activating the TLR4/NLRP3/caspase-1/GSDMD pathway, which results in aggravated pulmonary inflammation and diffuses silicon nodules [66, 83]. The gene discussed is CASP1; the disease is inflammation.